Patent details

EP2046349 Title: TREATMENT OF EXCESSIVE NEOVASCULARIZATION

Basic Information

Publication number:
EP2046349
PCT Application Number:
PCT/AU/2007/000974
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077846418
PCT Publication Number:
WO/2008/006168
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF EXCESSIVE NEOVASCULARIZATION
French Title of Invention:
TRAITEMENT DE LA NÉOVASCULARISATION EXCESSIVE
German Title of Invention:
BEHANDLUNG VON EXZESSIVER NEOVASKULARISATION
SPC Number:

Dates

Filing date:
12/07/2007
Grant date:
09/09/2015
EP Publication Date:
09/09/2015
PCT Publication Date:
17/01/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/04/2009
EP B1 Publication Date:
09/09/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/07/2016
Expiration date:
12/07/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/01/2016
 
 

Name:
Mesoblast Inc.
Address:
505 Fifth Avenue, Third Floor, New York, NY 10017, United States (US)

Inventor

Name:
RAKOCZY Piroska, Elizabeth
Address:
Australia (AU)

Priority

1

Priority Number:
830651 P
Priority Date:
12/07/2006
Priority Country:
United States (US)

2

Priority Number:
830649 P
Priority Date:
12/07/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 35/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages